Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Study shows how certain RNA molecules control the repair of damaged DNA in cancer cells

by Medical Finance
in News
PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A new study from Karolinska Institutet in Sweden shows how certain RNA molecules control the repair of damaged DNA in cancer cells, a discovery that could eventually give rise to better cancer treatments. The study is published today in the journal Nature Communications.

It was long assumed that RNA molecules – basic molecules that exist in all living organisms – only participated in protein synthesis. New research demonstrates, however, that RNA molecules have a much broader function and can play a key role in the development of disease.

One such disease in cancer, where damage to our cells’ DNA can be a contributing factor. DNA damage occurs and is repaired continuously, but in some cases it can lead to carcinogenic mutations in the genome. A fundamental understanding of how our cells repair DNA is therefore key to the design of new treatments.

In this current study, the researchers examined how certain RNA molecules affected the ability of the cancer cells to repair radiation-damaged or broken DNA strings. They discovered that two molecule types – small Cajal body-specific RNA 2 (scaRNA2) and WRAP53 – interacted to regulate the enzyme DNA-dependent protein kinase (DNA-PK), which in turn affected the DNA-repair mechanisms.

Works like an “on-off” button

“Our findings show that some RNA can bind to an enzyme that repairs damaged DNA and operate like an ‘on-off’ button for this enzyme, thereby controlling DNA repair,” says the study’s corresponding author Marianne Farnebo, researcher at the Department of Cell and Molecular Biology and the Department of Biosciences and Nutrition at Karolinska Institutet. “We’ve also discovered that altered levels of such RNA leads to faulty DNA repair in cancer cells.”

The researchers hope that the results can enhance understanding of the part played by RNA in DNA repair and cancer.

“This can open up new approaches to the treatment of cancer, such as using synthetic RNA molecules to stimulate cell death in cancer cells,” Marianne Farnebo says.

The study was supported with grants from the Swedish Cancer Society, the Swedish Research Council, the Centre for Innovative Medicine, the Cancer Research Funds of Radiumhemmet, Karolinska Institutet, the strategic research programme Cancer KI and the Wenner-Gren Foundations.

Source:

Journal reference:

“Small Cajal body-associated RNA 2 (scaRNA2) regulates DNA repair pathway choice by inhibiting DNA-PK”, Sofie Bergstrand, Eleanor M. O’Brien, Christos Coucoravas, Dominika Hrossova, Dimitra Peirasmaki, Sandro Schmidli, Soniya Dhanjal, Chiara Pederiva, Lee Siggens, Oliver Mortusewicz, Julienne J. O’Rourke and Marianne Farnebo, Nature Communications, online 23 February, 2022, doi: 10.1038/s41467-022-28646-5

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Monitoring the presence of enteric pathogens in imported seafood

Monitoring the presence of enteric pathogens in imported seafood

by Medical Finance
May 20, 2022
0

To monitor the presence of enteric pathogens in imported seafood, the authors of this paper collected a total of 140...

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

by Medical Finance
May 20, 2022
0

The iMolecule group from Skoltech has developed an artificial intelligence-driven solution that uses data on the structure of RNA or...

Excelitas technologies introduces µPAX-3 Pulsed Xenon Light Source

Excelitas technologies introduces µPAX-3 Pulsed Xenon Light Source

by Medical Finance
May 20, 2022
0

Excelitas Technologies Corp., a leading industrial technology manufacturer focused on delivering innovative, market-driven photonic solutions, announces the new µPAX-3 Pulsed...

Uno single tube reader

High resolution single tube reader

by Medical Finance
May 20, 2022
0

From Ziath LtdJan 12 2022Reviewed by Maria Osipova Ziath announce the Uno single tube reader – a powerful device packed...

Flowmeter Solutions for High-Speed Batch Dosing

Flowmeter Solutions for High-Speed Batch Dosing

by Medical Finance
May 20, 2022
0

Titan Enterprises has published a white paper reporting on an investigation into the use of electronic flow meters in high-speed...

NanoWizard V BioScience AFM

Bruker introduces fast BioAFM for automated mechanobiology

by Medical Finance
May 20, 2022
0

From Bruker JPKJan 12 2022Reviewed by Mychealla Rice Bruker today announced the release of the JPK NanoWizard® V BioAFM, a...

Next Post
‘Lefty’ protein pumps the brakes during initial stages of embryo differentiation

Using 'off-the-shelf' engineered stem cell based therapy for treating glioblastomas post-surgery

VANTAstar

Micro Products with Macro Impact; The Role of Microplate Readers in Life Sciences

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Demonstration of Hollow Fiber Membrane-Based Enclosed Space Air Remediation for Capture of an Aerosolized Synthetic SARS-CoV-2 Mimic and Pseudovirus Particles. Image Credit: NokkieVector / Shutterstock.com
    Hollow fiber membranes efficiently remove synthetic SARS-CoV-2 from the air
  • PI-KARE™ technology: a skin-friendly, non-sensitizing polyisoprene formulation
    A skin-friendly, non-sensitizing polyisoprene formulation
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply